Is there discrimination in access to therapy for HCV patients?

Silvio Garattini

doi:10.1016/j.jhep.2008.07.003

Is there discrimination in access to therapy for HCV patients?

Istituto di Ricerche Farmacologiche "Mario Negri"

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	491-493
Number of pages	3
Journal	Journal of Hepatology
Volume	49
Issue number	4
DOIs	https://doi.org/10.1016/j.jhep.2008.07.003
Publication status	Published - Oct 2008

Keywords

Hepatitis C
Market access
Market uptake
Peginterferon
Ribavirin

ASJC Scopus subject areas

Gastroenterology

Access to Document

10.1016/j.jhep.2008.07.003

Cite this

@article{6b577f609caf4d57a3af3a841f6d2c3d,

title = "Is there discrimination in access to therapy for HCV patients?",

keywords = "Hepatitis C, Market access, Market uptake, Peginterferon, Ribavirin",

author = "Silvio Garattini",

year = "2008",

month = oct,

doi = "10.1016/j.jhep.2008.07.003",

language = "English",

volume = "49",

pages = "491--493",

journal = "Journal of Hepatology",

issn = "0168-8278",